[Key words: cannabinoid, calcium current, G protein, potassium current, anandamide] Cannabinoids, the primary psychoactive constituents of marijuana, have profound effects on mood, perception, and memory. Most of these effects appear to be mediated via the brain (CB-1) cannabinoid receptor (Pertwee, 1993) . This receptor is a member of the G protein-coupled receptor superfamily (Matsuda et al., 1990) and previously has been shown to couple in an inhibitory fashion to adenylyl cyclase (Howlett, 1985) and N-type calcium channels (Caulfield and Brown, 1992; Mackie and Hille, 1992) . In neurons and other excitable cells, several G protein coupled receptors also activate inwardly rectifying potassium channels via a pertussis toxin sensitive G protein (North, 1989; Kubo et al., 1993) . These channels often contribute to setting the resting membrane potential and play a major role in determining neuronal excitability. In addition to N-type calcium channels, some neuronal G protein-coupled receptors also appear to be able to modulate P-type Zca and other, less well characterized, voltage-dependent calcium channels (Mintz and Bean, 1993) . We asked the question if the same was true for CB-1 receptor. Lacking a neuronal preparation expressing the appropriate ion channels and cannabinoid receptor, and desiring to establish a system for investigating cannabinoid receptor-effector coupling, we transfected the mouse tumor cell line, AtT20, with rat CB-1 receptor. This cell line was chosen as it expresses an inwardly rectifying potassium current that is activated by somatostatin (Dousmanis and Pennefather, 1992; Pennefather et al., 1988) and m, muscarinic receptors (Jones, 1992) . In addition it expresses high voltage-activated calcium currents that are inhibited by G protein-coupled receptors (Luini et al., 1986; Surprenant et al., 1992) . AtT-20 cells secrete B-endorphin and ACTH and have served as a useful model for studying neuropeptide synthesis, transport and release (Burgess and Kelly, 1987; Matsuuchi and Kelly, 1991) . Although they are often assumed to be closely related to pituitary corticotrophs, strong evidence has been presented that these cells have many enzymatic and structural features more in common to neuropeptide secreting neurons (Tooze et al., 1989) . Thus, they may be a more appropriate model to study neuronal processes than previously appreciated. By determining how cannabinoid receptors couple to ion channels, we hope to increase our understanding of the mechanisms underlying the behavioral actions of cannabinoids and the endogenous ligands for this receptor.
The indentification and classification of voltage-dependent calcium channels is still evolving (Birnbaumer et al., 1994) . In the rat brain, multiple isoforms of the principal a, subunit of voltage-dependent calcium channels have been identified using molecular cloning techniques and have been designated class A, B, C, D, and E (Snutch et al., 1990; Snutch and Reiner, 1992; Birnbaumer et al., 1994; Soong et al., 1994) . The rat brain class C and D genes encode L-type calcium channel (Y, subunits (a,, and 01~~) which have a high affinity for dihydropyridine calcium channel antagonists and are approximately 75% identical in amino acid sequence with rabbit skeletal muscle calcium channels and L-type calcium channels from other tissues (Snutch et al., 1990; Hui et al., 1991; Chin et al., 1992; Dubel et al., 1992; Seino et al., 1992; Williams et al., 1992; Tomlinson et al., 1993) . The rat brain class B gene encodes N-type calcium channel (Y, subunits with high affinity for w-conotoxin-GVIA Williams et al., 1992) . The class A gene encodes cx, subunits which form a high-voltage-activated calcium channel with novel physiological and pharmacological properties and is highly expressed in the cerebellum (Mori et al., 1991; Starr et al., 1991; Sather et al., 1993) . The class A channels are insensitive to dihydropyridines and w-conotoxin-GVIA, weakly blocked by o-agatoxin-IVa, and completely blocked by o-conotoxin MVIIC. The functional properties of class A (Y, subunits are distinct from the physiologically defined N-type and P-type calcium channels, but closely resemble those of calcium channels in cerebellar granule cells which have been designated Q-type Randall and Tsien, in press ). Functional expression of class E (a,,) in Xenopus oocytes produced rapidly inactivating calcium channels insensitive to high affinity organic and peptide calcium channel blockers (Williams et al., 1992; Soong et al., 1994; Randall and Tsien, in press ). The currents conducted by (Y,~ are similar in some respects to T-type calcium currents as well as the recently identified R-type and Gl-3 calcium channels in cerebellar granule cells (Forti et al., 1994; Randall and Tsien, in press ). However, the precise relationship between (~,r and native calcium currents remains to be defined. In this study, using antibodies and channel blockers, we have characterized the calcium channels present in AtT-20 cells.
Materials and Methods
Materials. Tissue culture reagents were from GIBCO, BSA, leupeptin, IBMX, and PMSF from Sigma, PTX from List, oAgaIVa from Peptides International, leupeptin and oCgTX GVIA from-Bachem, 3H-WIN 55.212-2 was from New England Nuclear. wCTX MVIIC (SNX 230) from Neurex, somatostain and oCgTX GVIA from Peninsula Labs and TTX and GTP from Calbiochem. Synthetic anandamide was provided by both William Devane and Raphael Mechoulam and its purity verified as previously described . WIN 55,212.2 and WIN 55,212-3 were gifts from Sterling Research Group.
Cell culture. For electrophysiological recording, A-2 cells were plated on polylysine-coated coverslips and grown in DMEM + 10% heatinactivated horse serum + 1:200 penicillin/streptomycin + 400 pg/ml G418 in a humidified environment with 10% CO, at 35°C. For binding and adenylyl cyclase studies, A-2 cells were grown on 500 cm* tissue culture plates (NUNC) using the above conditions. Cells were passaged using 0.05 mg/ml trypsin in phosphate-buffered saline (PBS) and used within 10 passages after the initial clone was isolated.
Cunnabinoid receptor expression. PCR amplification was used to introduce restriction sites on each side of the cannabinoid receptor cDNA to facilitate subcloning of the gene from SKR6 (Matsuda et al., 1990) into the ocDNA3 mammalian expression plasmid (Invitrogen). Primers (5'-CGGGATCCaAAGTCGkCCTAGATGGCTTGS and 5'-CGGGATCCATGGCACAAAAGCAGCAGCTCACAGAGC-3') and pfu polymerase were used to amplify the CB-1 receptor cDNA' from the SKR6 plasmid. The resulting PCR product was first subcloned into the BumHI site of pUC19 and then subcloned into the BumHI site of pcDNA3 (CB-1 -pcDNA3). Colonies containing CB-1 -pcDNA3 were identified by hybridization with a 32P-labeled cannabinoid receptor oligonucleotide @CR sense primer) and the correct orientation was verified by restriction digests with Hi&II. AtT20 cells were transfected by the calcium phosphate technique with purified (ProMega) CB-l-pc-DNA3. Selection was carried out for 10 d in G418, several positive colonies exoanded and screened bv jH-WIN 55.212-2 binding.
Radioligind binding and adenyiyl cyclase activity. For binding studies, AtT20 cells transfected with pcDNA3 (control) or CB-1 were grown to confluency in 500 cm* plates. The monolayers were washed twice with TEM (in mM: 25 Tris-HCl, 6 MgCl,, 1 EDTA, 10 PM phenylmethylsulfonyl fluride (PMSF), and 1 (*g/ml leupeptin, pH 7.4) and homogenized in TEM (1 ml/plate). The homogenate was centrifuged at 800 X g for 10 mitt, the resulting pellet homogenized in TEM and spun at 800 X g for 10 min. The combined supematants were resuspended, centrifuged at 100,000 X g for 1 hr and the pellets were homogenized in TEM at a final protein concentration of l-5 mg/ml. Membranes (50 pg) were incubated in 20 mM Hepes and 1 mg/ml bovine serum albumin (BSA), pH 7.5 (final volume 200 ml) in 0.325-6 nM 3H WIN 55,212-2. After 90 min at 3O"C, the membranes were filtered on a Tomtec Harvester 96 programmed to rapidly filter and wash captured membranes with 3 X 5 ml Hepes/BSA (Kuster et al., 1993) . Specific binding was defined as the fraction of binding displaced by 1 &LM of unlabeled WIN 55,212-2. Saturation studies were analyzed by computer using the INPLOT program. For adenylyl cyclase studies, A-2 cells grown on 24 well plates were rinsed twice with PBS and preincubated first with DMEM for 60 min, and then the DMEM, 1 mM isobutylmethylxanthine, and 3 PM BSA for 10 min. When appropriate, 100 nM WIN 55,212.2 or WIN 55,212-3 was added and the sample incubated for 5 min. The samples were next incubated for 10 min at 37°C with or without 10 JLM forskolin, lysed with 0.1 N HCl and CAMP measured using a scintillation proximity assay kit (Amersham).
Electrophysiological recording. Currrents were recorded using the whole-cell voltage-clamp technique (Hamill et al., 1980) . Pipettes were pulled from microhematocrit glass (VWR) and fire polished. For recording, a coverslip containing cells was transferred to a 200 pl chanber that was constantly perfused (l-2 ml/min) with the appropriate external solution. Solution reservoirs were selected by means of a series of solenoid valves, and solution changes were accomplished in < 1 min. Voltage protocols were generated and data were digitized, recorded, and analyzed using BASIC-FASTLAB (Indec Systems, Capitola, CA). Junction potentials are uncorrected.
For measuring potassium currents, the pipette solution contained (mM): 130 KCl, 20 Hepes, 10 EGTA, 5 MgCl,, 3 Na,ATP, 0.6 GTP, 0.08 leupeptin, pH 7.25 with KOH, while the external solution contained (mu): 20 KCl, 130 NaCl (or N-metbylglucamine-NMG), 1 CaCl,, 25 Hepes, 10 glucose, pH 7.35 with NaOH. Fatty acid-free bovine serum albumin (BSA) (3 pM) was added to decrease adsorbtion of cannabinoids. In some experiments to increase the amplitude of the potassium currents the concentration of KC1 was increased to 30 or 40 mM and the concentration of NaCl or NMG decreased correspondingly, to take advantage of the relationship between [K] , and the voltage dependence of K, current gating. The K,, current was defined as that component of the current sensitive to 1 mu BaZ+ elicited during the final 150 msec of a 250 msec hyperpolarizing pulse to -100 mV from a holding potential of -45 mV. Currents were sampled at 1 kHz. As the magnitude of the K,, current was dependent on cell size, aggregate current data are presented as current densities normalized to cell capacitance.
For measuring calcium currents, the pipette solution contained (mu): 100 CsCl, 40 Hepes, 10 EGTA, 5 MgCl,, 3 Na,ATP 0.2 GTe, 0.08 leupeptin, pH 7.30 with CsOH, while the external solution contained (mu): 160 NaCl, 5 CaCl,, 4 KCl, 1 MgCl,, 10 Hepes, 8 glucose, pH 7.35 with NaOH. Tetrodotoxin (200 nM) was added to block voltagedependent sodium currents and BSA was added to decrease adsorbtion of the cannabinoids, as described above. In experiments using peptide calcium channel blockers, 8 PM cytochrome c was substituted for 3 FM BSA. This substitution had no effect on Ic, or its modulation by WIN 55,212-2 (see Fig. 5A -C). Zc, was measured near the end of a -25 ms depolarizing pulse to 0 mV from a holding potential of -90 mV and was defined as that component of the current sensitive to 100 p,~ CdCl,. Currents were sampled at 4 kHz.
To control for possible response variations with passage number and to avoid one source of systematic bias, experimental and control measurements were alternated whenever possible and concurrent controls were always performed. Where appropriate, data are expressed as mean -C standard error.
Production and purijcation of peptides and antibodies. The antibodies CNB2, CNCl, and CNDl were prepared as described previously (Hell et al., 1993; Westenbroek et al., 1992) . Peptides CNAl (KYPSS-PERAPGREGPYGRE), corresponding to residues 865-881 and CNE2 (KYSASQERSLDEGVSIDG), corresponding to residues 896911, of the ~1, subunit of rat brain class A and E calcium channels, respectively, plus N-terminal lysine and tyrosine extensions, were synthesized by the solid phase method (Merrifield, 1963) . The peptides were purified by reverse-phase HPLC on a Vydac 218TPlO column and their identity verified by amino acid analysis.
Anti-peptide antibodies against the CNAl or CNE2 peptides were generated using the method described previously (Westenbroek et al., 1992) . Briefly, the purified peptide CNAl or CNE2 was coupled through amino groups with glutaraldehyde to bovine serum albumin (Orth, 1979) , dialyzed against PBS, and emulsified in an equal volume of Freund's complete (initial injection) or incomplete adjuvant. At 3 week intervals, the coupled peptide was injected into multiple subcutaneous sites on New Zealand White rabbits. Antisera were collected after the second injection and tested by enzyme-linked immunosorbent assay using microtiter plates with welis coated with 0.5 mg of peptide (Posnett et al.. 1988 ). Antibodies against CNAl or CNE2 ueotides were purified by affinity 'chromatography on CNAl or CNEi peptides, respectively, which were coupled to CNBr-activated Sepharose. The antiserum (2.0 ml) was bound to the column at 4°C overnight, washed with TBS, eluted with 5.0 M MgCl, and then dialyzed against TBS using a Centriprep 30 (Amicon).
Immunocytochemistry. A-2 cells were grown on 35 mm plastic petri dishes for 3-5 d. The cells were rinsed briefly in 0.05 M PB (sodium phosphate, pH 7.4), and fixed for 20 min using 4% paraformaldehyde in 0.1 M PB. The cells were next rinsed with PB briefly followed by 0.05 M PBS (sodium phosphate-buffered saline, pH 7.4) for 30 mins, and then blocked with 10% Avidin (Vector) in PBS for 30 min. The cells were then rinsed in PBS for 20 mins, blocked with 10% Biotin (Vector) in PBS for 30 min, rinsed in PBS for 20 min, and then blocked using 5% normal goat serum in PBS. The cells were incubated overnight at 4°C in affinity purified CNAl (diluted 1:15), CNB2 (diluted 1:20), CNCl (diluted 1:15), CNDl (diluted 1:15), or CNE2 (diluted 1:20) antibodies. All antibodies were diluted in PBS containing 10% normal goat serum and 0.025% Triton X-100. The cells were then rinsed with PBS for 45 min and incubated for 2 hr at room temperature in Biotinylated goat anti-rabbit IgG (diluted 1:400,Vector), rinsed in PBS for 45 mins, and then in incubated in Avidin-D-fluorescein (diluted 1:400, Vector). The cells were finally rinsed in PBS for 10 min, PB for 20 min, distilled water for 5 min, and then coverslipped using Vectashield (Vector). All samples were viewed and photographed using a Bio-Rad confocal microscope. Controls included incubating cells without primary antibody or blocking the primary antibody by preincubation for 6 to 8 hr with the corresponding peptide (20-25 PM). The immunocytochemical reaction was then carried out as described above. The staining patterns reported here were abolished in cells treated without primary antibody or with blocked primary antibody.
Results
Establishment of a cell line stably expressing CB-1 After transfection with CB-l-pcDNA3 and selection in 400 pg/ ml G418, the clone designated A-2 was chosen for further characterization. Membranes prepared from A-2 cells consistently showed saturable binding for the synthetic cannabinoid ligand 3H WIN 55,212-2 (Fig. lA) , with a B,, of 864 2 13 fmol/mg protein and a Kd of 2.6 + 0.7 nM (n = 6). Specific binding ranged from 60 to 80% of the total binding. In contrast, membranes prepared from AtT20 cells transfected with the vector pcDNA3 alone showed no specific binding to 3H WIN 55,212-2 (n = 3, data not shown). CB-1 expressed in AtT20 cells coupled appropriately to adenylyl cyclase, with 100 nM WIN 55,212-2 inhibiting forskolin-stimulated adenylyl cyclase by about 50% (Fig. 1B) . Its enantiomer, WIN 55,212-3, was inactive (Fig. 1B) .
Cannabinoids activate an inwardly rectifying potassium conductance Exposure of an A-2 cell to 100 nM WIN 55,212-2 activated a prominent inward current when the cell was hyperpolarized to a potential negative to E, in high potassium external ( Fig. 2A) . This response was seen in more than 90% of the cells tested (data not shown). The current-voltage relationship for the WIN 55,212-2-induced current showed inward rectification over the voltage range of 0 to -90 mV (Fig. 2B ). This current was also sensitive to low concentrations of barium (Fig. 2C) (Hagiwara et al., 1978; Dousmanis and Pennefather, 1992) . Both of these are features of the inwardly rectifying potassium current activated by somatostain and muscarinic agonists previously identified in these cells (Pennefather et al., 1988; Jones, 1992) . Thus, we will refer to this current as inwardly rectifying potassium current or Ki, current. WIN 55,212-2 failed to increase K,, cur-A . rent in AtT20 cells transfected with the pcDNA3 plasmid alone (0.09 + 0.18 pA/pE n = 4, data not shown). However, 200 nM somatostatin robustly activated K, current in these cells as expected (Pennefather et al., 1988 ) (data not shown). In N18 neuroblastoma cells and NG108-15 neuroblastoma glioma cells WIN 55,212-Zmediated inhibition of N-type I,, is half-maximal at about 10 nM (Mackie and Hille, 1992; Mackie et al., 1993) . Similarly, in A-2 cells WIN 55,212-2 potently activated K, current with an EC50 of 12 2 4 nM (Fig. 20) . Binding and activation of K, current did not show marked coopera- pAJpF, n = 6; 11.5 2 2.3 pA/pP n = 9; and 8.6 t 4.0 pAlpP n = 7, respectively, at -100 mV (data not shown). Thus somatostatin appears to be a more efficacious activator of K,, in these cells than either WIN 55,212-2 or oxotremorine-m. As AtT-20 cells only express about 200 fmol/mg of somatosatin receptors (about 19,000 receptors/cell) (Thermos and Reisine, 1988) , the increased efficacy of somatostatin cannot be due to a higher receptor density and may occur at the level of the G protein.
Anandamide, an endogenous ligand for the brain cannabinoid receptor has been identified, isolated, synthesized and characterized (Devane et al., 1992; Felder et al., 1993; Mackie et al., 1993) . In N18 neuroblastoma cells, anandamide has a lower intrinsic efficacy than the potent synthetic cannabinoids CP 55,940 and WIN 55,212-2 , acting as a partial agonist for inhibition of N-type I,,. Thus, it was of interest to see if anandamide acts as a partial agonist in activation of K, current. This appears not to be the case as K, current is activated to a similar extent by application of 300 nM anandamide or by application of 100 nM WIN 55,212-2 (Fig. 3A,B) .
Cannabinoids inhibit I, via a voltage-dependent and PTXsensitive pathway
In neuroblastoma cell lines cannabinoids inhibit N-type Zca (Caulfield and Brown, 1992; Mackie and Hille, 1992; . We found that cannabinoids also inhibit high voltageactivated Zca in A-2 cells (Fig. 4A,C) . This response was seen in more than 95% of the cell that expressed Z,, (data not shown). A common form of high voltage-activated I,, modulation is a voltage-dependent inhibition that can be transiently overcome by application of large depolarizing prepulses (Bean, 1989; Marchetti et al., 1986) , that is, prepulse facilitation. In mammalian cells, many receptors coupled to PTX-sensitive G proteins, including the cannabinoid CB-1 receptor, produce such voltagedependent inhibition (Ikeda, 1991; Kasai, 1992; Mackie et al., 1993) . Voltage-dependent inhibition can be assessed by first subjecting the cell to a brief depolarization to 0 mV to obtain the baseline calcium current. After a pause of 2 set, the cell is Activate K,, Current and Inhibit Q-type Ic. and then stepped to 0 mV to measure the facilitated calcium current (see the voltage protocol in Fig. 4A as an example). A comparison of the I,, during the first and second test pulses will give a measure of the facilitation that occurs during the depolarizing prepulse. During the application of an agonist that shows voltage-dependent inhibition, the reduction of Zca during the first, baseline pulse will be greater than during the second, facilitated pulse. The degree of relief from agonist-induced inhibition during the facilitated pulse is a measure of the voltage dependence of the inhibition.
--------------------------------------
The effect of cannabinoids on Zc, in A-2 cells was determined using the double pulse voltage protocol shown in Figure 4A . Bath application of 100 nM WIN S&212-2 inhibited about 25% of the current during the first test pulse (Fig. 4A ), but only 10% of the current during the second, facilitated pulse. On average, inhibition of I,, by 100 nM WIN 55,212-2 was 60 ? 7% voltage dependent (n = 6) (data not shown). . WIN 55,212-2 inhibits a high voltage-activated I,, in AtT20 cells expressing rat brain cannabinoid receptor in a voltage-and PTXsensitive fashion. A, Calcium currents were measured using a double pulse protocol. After a pause of 2 set, the first test pulse was followed by a 50 msec depolarization to 100 mV, a 5 msec repolarization to -80 mV and a second test pulse to 0 mV, 100 nM WIN 55,212-2 inhibited approximately 25% of the &, during the first pulse, but only 10% of the Ic, during the second pulse indicating voltage dependence. Traces were CdZ+ (100 PM) subtracted. B:Lefi, overnight incubation with 500 rig/ml PTX effectively blocked modulation of I,-, in AtT20 cells expressing rat CB-1. Right did not inhibit I,. (0.9 -+ l.l%, n = 4, data not shown). Similarly, as was found for activation of K,,, modulation of I,, by 100 nM WIN 55,212-2 is mediated via G protein(s) of the Gi or G, class, as overnight incubation of A-2 cells with 500 rig/ml PTX abolished WIN 55,212-2-induced Zc, inhibition (Fig. 4B,  left) . Application of 300 nM anandamide inhibited I,, as efficaciously as 100 nM WIN 55,212-2 (Fig. 4B, right) . Inhibition of I,, by WIN 55,212-2 was potent, being half-maximal at 11 nM (Fig. 40) , and noncooperative, with a Hill coefficient of 1.1.
Cannabinoids inhibit a non-L, N, P, T calcium current We next determined which subtype(s) of I,, cannabinoids inhibited in A-2 cells. Previous studies have found that AtT20 cells do not express a functional low-voltage-activated, or T-type, calcium current (Luini et al., 1986; Surprenant et al., 1992) . Similarly, A-2 cells do not appear to express this current (Fig. 4C) . Although the classification of high voltage-activated calcium currents in excitable cells is still developing, a classification useful for interpreting data from electrophysiological experiments is based on the sensitivity of different calcium currents to dihydropyridines and peptide toxins. For this study, we delined L-type calcium current as that Zc, sensitive to the dihydropyridine, nifedipine; P type I,, was defined as that component of the current sensitive to low concentrations of the spider toxin, wAga IVa; N-type Zca was defined as the current sensitive to the conus toxin, oCgTX GVIA. In many neurons, a significant high voltage-activated Zc, remains after treatment with a cocktail of the above blockers. This current is often sensitive to the conus toxin, oCTX MVIIC, appears to play a role in neurotransmitter release, can be modulated by G protein coupled receptors, and has tentatively been labeled as Q-type I,, Sather et al., 1993; Wheeler et al., 1994; Zhang et al., 1993) . The residual high voltage-activated current after treatment with dihydropyridines and oCTX MVIIC has been designated "R-type" by some investigators (Randall and Tsien, in press) although this current might actually consist of several components.
We first pharmacologically determined the high voltage-activated calcium current types present in AtT-20 cells. Nifedipine (2 p+M) blocked about a third of the whole cell I,, elicited by a depolarization to 0 mV from a holding potential of -90 mV (Fig. 5A) . In cells pretreated with 2 pM nifedipine, 200 nM oAga IVa was ineffective in blocking I,, (Fig. 5A) , while 1 p,~ oCgTX GVIA blocked less than 10% of Zca (Fig. 5A) . Therefore, AtT-20 cells don't express P-type I,, and express low levels of N-type I,,. However, 5 pM &TX MVIIC slowly blocked approximately 50% of the I,, in these cells (Fig. 5A,D) . Inhibition during &TX MVIIC application did not appear to be a consequence of rundown as calcium currents were fairly stable un-der the present recording conditions (Fig. 5A,C) . Thus AtT-20 cells are distinctive among cell lines examined thus far in that they express a significant Q-type Zc..
We next determined the component of I,, cannabinoids inhibited. WIN 55,212-2 does not appear to inhibit L-type I,,, as block of these channels by 2 FM nifedipine does not decrease the fraction (normalized to prenifedipine levels) of Zca inhibited by 100 nM WIN 55,212-2 (Fig. 5B) . As an expected consequence of their modest effects on whole cell Ica, prior application of 200 nM oAga IVa or 1 pM wCgTX GVIA did not significantly alter I,, inhibition by 100 nM WIN 55,212-2 (Fig. 5B) . In contrast, prior treatment by 5 pM wCTX MVIIC reduced subsequent inhibition by 100 nM WIN 55,212-2 from 31 t 3.3% (n = 7) to 8 2 1.2% (n = 6) (Fig. 5&D) . Thus the majority of the WIN 55,212-2-inhibited I,, is carried via Q-type calcium channels sensitive to wCTX MVIIC but insensitive to nifedipine, oAga IVa, or wCgTX GVIA.
Immunocytochemical identification of class A, B, C, D, and E calcium channels in A-2 cells Immunocytochemistry was carried out to further verify the presence of L-, N-, and Q-type calcium channels in the A-2 cell line, using anti-peptide antibodies specific to class A (CNAl), class B (CNB2), class C (CNCl), class D (CNDl), or class E (CNE2) neuronal calcium channels. The biochemical properties and localization of CNAl and CNB2 antibodies in rat brain have been reported previously (Westenbroek et al., 1992 Hell et al., 1993) . Using the CNAl antibody we observed a relatively dense pattern of staining in the cell body and along the extensions of the A-2 cells (Fig. 6A) . Occasionally there was staining in the foot processes of the cells, however, staining in this region was variable. The pattern of CNB2 antibody localization (Fig. 6B ) was similar to that observed for the CNAl antibody. There was specific CNB2 staining in the cell body, along the extensions and in the foot process. The CNB2 staining in the foot process was much more common than staining of this region with the CNAI antibody. The pattern of staining for CNAl and CNB2 antibodies appears to be punctate, suggestive of clustering of calcium channels. In addition, the staining appears to be mainly in the membrane as suggested by a z-series through several cells at 1 pm steps. The immunoreactivity observed with the CNCl and the CNDl antibodies was localized predominatly to the cell body and in the proximal portion of the extensions (Fig. 6C,D) . Occasionally, there was relatively faint staining of CNDl in the foot process. The staining with the CNCl also appeared to be punctate. In N18 neuroblastoma cells the high-voltage-activated I,, is blocked by a combination of 2 p,M nifedipine and 1 p,M wCgTX GVIA, implying that class B, C, and/or D, but not A, calcium channels are functionally expressed . Consistent with this electrophysiological observation, N18 cells were intensely labeled with antibodies against class B, C, and D channels, but not with antibodies against class A channels (data not shown).
Antipeptide antibodies to class E calcium channels (Yokoyama et al., 1995) were also used to investigate the presence of other voltage-dependent calcium channels in A-2 cells. Using CNE2 antibodies we observed a relatively dense pattern of staining in the cell body of A-2 cells (Fig. 6E ). There was also weak CNE2 staining along the extensions with relatively little staining observed in the foot process. We observed no staining with the CNE2 antibody in N18 cells. The current electrophysiological studies suggest that R-type currents are present in A-2 cells and earlier work demonstrates a prominent T-type current in N-18 cells Mackie, unpublished observations) . Thus, our immunocytochemical results are consistent with the, hypotheses that class E calcium channels mediate "R-type" currents in A-2 cells and they do not mediate T-type currents in N18 cells. Control sections in which the primary antibody was omitted (Fig. 6F) indicate that the staining observed using the CNAl, CNB2, CNCl, CNDl, or CNE2 antibodies is specific.
Collectively our studies confirm the presence of class A (Qtype), class B (N-type), class C and D (L-type), and class E (R type?) calcium channels in the A-2 cells. Since this is not quantitative immunocytochemistry, the differences in the relative amount of staining among the antibodies can not be interpreted as absolute differences in the amount of channel present. The staining depends on such variables as the titer of the antibodies and the access of the antibody to the antigenic site.
Discussion
Here we have found that cannabinoids activate a K, current and inhibit a Q-type I,, in AtT20 cells transfected with the rat brain cannabinoid receptor. Thus, it is likely that cannabinoids will do the same in neurons expressing the cannabinoid receptors, these ion channels, and N-type calcium channels. Our favored interpretation of the results of these and earlier studies is that activation of the cannabinoid receptor decreases the excitability of those neurons expressing it. Specifically, inhibition of N-and Q-type calcium currents will decrease the likelihood of neurotransmitter release and successful synaptic transmission as well as suppressing other calcium-dependent processes. Activation of K,, currents will decrease excitability by holding the membrane potential negative to the activation threshold for sodium and calcium channels making pre-and postsynaptic depolarization, action potential generation, and impulse propagation less likely.
AtT20 cells transfected with the rat brain cannabinoid receptor (A-2 cells) expressed functional cannabinoid receptors as evidenced by the development of specific WIN 55,212-2 binding sites and the ability of WIN 55,212-2 to inhibit forskolin-stimulated adenylyl cyclase. The inward current activated by cannabinoids in A-2 cells has the characteristics of a K, currentit was sensitive to 1 mu Ba2+ and its current-voltage relationship showed inward rectification (Fig. 2B) . Activation of K, current by cannabinoids in A-2 cells appears similar in most regards to activation of similar currents in other cells and neurons as it is mediated by a PTX-sensitive G protein (North, 1989) .
The endogenous cannabinoid, anandamide, has a lower intrinsic efficacy than the potent synthetic cannabinoids, WIN 55,212-2 or CP 55,940 . In N18 cells, anandamide acts as a partial agonist in inhibiting N-type Zca. In this study partial agonism by anandamide was not found for either activation of K, current or inhibition of Q-type I,,. This might be a consequence of A-2 cells having a higher density of CB-1 receptors than N18 cells (< 100 fmol/mg, data not shown), or because different G proteins transduce the response (Hoyer and Boddeke, 1993) . In either case, because of the high density of cannabinoid receptor expression in many brain regions, anandamide likely acts as a full agonist in activation of K,, current or inhibition of Q-type I,, in those regions.
Cannabinoids inhibit N-type calcium channels in N18 and NG108-15 cells (Mac&e and Hille, 1992; Mackie et al., 1993) , two cell lines descended from a murine peripheral neuroblastoma. N-type I,, mediates a portion of neurotransmitter release at some mammalian CNS synapses (Takahashi and Momiyama, Figure   6 . Localization of class A-E calcium channels in A-2 cells. A-2 cells were stained using the immunofluoresence technique as described in Materials and Methods. A, A-2 cells stained with CNAl antibody to rat brain class A calcium channels. B, A-2 cells stained with the CNB2 antibody against the rat brain class B N-type calcium channels. C, Cells labeled with CNCl demonstrating the presence of class C L-type calcium channels. D. A-2 cell line labeled with class D L-tvoe calcium channels. E, A-2 cells stained with CNE2 antibodv against the rat brain class E calcium channels. F, A-2 cells with primary antibo& omitted. Scale bar, 10 pm. _ -1993; Turner et al., 1993; Wheeler et al., 1994) . It is likely that cannabinoid agonists decrease neurotransmitter release in presynaptic terminals expressing cannabinoid receptors and N-type Zca. Recent studies have implicated Q-, 0-, or possibly other types of I,, (defined as being insensitive to wCgTX GVIA and dihydropyridines, sensitive to only high concentrations of wAga IVa, and sensitive to &TX MVIIC; Adams et al., 1993; Zhang et al., 1993) and P-type I,, (sensitive to low concentrations of wAga IVa) as major facilitators of neurotransmission at mammalian CNS synapses (Wheeler et al., 1994) . It has been proposed based on differential toxin sensitivities that the Q-type current described in cerebellar granule cells corresponds to the Ba*+ current described in Xenopus oocytes expressing a rabbit OL,, (together with rabbit a,/6 and p subunits) calcium channel . The G protein modulation of Q-type I,-= found in the current study appears to have at least two properties in common with modulation of N-type I,,. In particular, it is voltage dependent and PTX-sensitive (Mintz and Bean, 1993; Swartz, 1993; Wheeler et al., 1994 ; current study). The pharmacology of the I,, inhibited by cannabinoids in CB-I-transfected AtT-20 cells is similar to that described for Q-type Zc. Randall and Tsien, in press ). As activation of m, muscarinic and somatostatin receptors also inhibit most of the dihydropyridine-insenstive Zca in these cells in a voltage-dependent fashion (data not shown), it is likely that these receptors can also inhibit Q-type I,, in neurons. It is possible that Q-type current may actually be composed of several components, but the present operational definition of Q-type I,, as a I,, insensitive to oCgTX GVIA and dihydropyridines, sensitive to high concentrations of oAga IVa, and sensitive to oCTX MVIIC is useful. There are two differences between Q-type I,, previously defined Randall and Tsien, in press ) and our present results. The first is that 200 nM oAga IVa was ineffective at blocking I,, in our experiments, whereas this concentration of wAga IVa did block a portion of the I,, in oocytes expressing rabbit (Y,* . This may be a consequence of a charge carrier, species, or expression difference. The second is that 5 pM wCTX MVIIC blocked only about 50% of the dihydropyridine-insensitive current in A-2 cells. The immunocytochemical detection of class E calcium channels in these cells suggests that at least a portion of the &TX MVIICinsensitive or "R-type" I,, is carried via these channels. It is also possible that &TX MVIIC block had not come to completion after 5 min with our recording conditions. It has been noted that &TX MVIIC block is slow in onset compared to other peptide blockers Wheeler et al., 1994) . Supporting the incomplete block hypothesis is the observation that block was greater (58%, IZ = 2) and WIN 55,212-2 I,,-inhibition less (4%, n = 2) after 10 min of toxin exposure. This latter observation also suggests that cannabinoids modulate "Rtype" L weakly, if at all. Another explanation for incomplete block is that &TX MVIIC block is dependent on external divalent concentration, being prevented by 40 mu Ba2+ , and 5 mu Ca2+ was used in the current study. In summary, as CB-1 receptors are highly concentrated at presynaptic endings in the CNS, including at some endings that have few N-type calcium channels (Herkenham et al., 1991; Matsuda et al., 1993) , cannabinoid-mediated inhibition of Q-type I,, is a potential mechanism to decrease neurotransmission and other calcium dependent processes at these synapses. Whether this is the basis for some or all of the psychoactive effects of the cannabinoids awaits further experimentation.
